Abstract:Mai Zhang, 1 Yan Li, 1, 2 Chunli Han, 3 Shiying Chu, 1 Peng Yu, 1 Wenbo Cheng 1, 2 1 Mass Spectrometry Application Center, Tianjin Guoke Medical Technology Development Co., Ltd, Tianjin, People's Republic of China; 2 Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (CAS), Suzhou, People's Republic of China; 3 Mass Spectrometry Application Center, Shandong CAS Intelligent Manufacturing Medical Device Technology Co., Ltd, Zaozhuang, People's Republic of China Correspondence: Wenbo Cheng, Email Background: Inhibition of amyloid β protein fragment (Aβ) aggregation is considered to be one of the most effective strategies for the treatment of Alzheimer's disease. (-)-Epigallocatechin-3-gallate (EGCG) has been found to be effective in this regard; however, owing to its low bioavailability, nanodelivery is recommended for practical applications. Compared to chemical reduction methods, biosynthesis avoids possible biotoxicity and cumbersome preparation processes. Materials and Methods: The interaction between EGCG and Aβ 42 was simulated by molecular docking, and green tea-conjugated gold nanoparticles (GT-Au NPs) and EGCG-Au NPs were synthesized using EGCG-enriched green tea and EGCG solutions, respectively. Surface active molecules of the particles were identified and analyzed using various liquid chromatography-tandem triple quadrupole mass spectrometry methods. ThT fluorescence assay, circular dichroism, and TEM were used to investigate the effect of synthesized particles on the inhibition of Aβ 42 aggregation. Results: EGCG as well as apigenin, quercetin, baicalin, and glutathione were identified as capping ligands stabilized on the surface of GT-Au NPs. They more or less inhibited Aβ 42 aggregation or promoted fibril disaggregation, with EGCG being the most effective, which bound to Aβ 42 through hydrogen bonding, hydrophobic interactions, etc. resulting in 39.86% and 88.50% inhibition of aggregation and disaggregation effects, respectively. EGCG-Au NPs were not as effective as free EGCG, whereas multiple thiols and polyphenols in green tea accelerated and optimized heavy metal detoxification. The synthesized GT-Au NPs conferred the efficacy of diverse ligands to the particles, with inhibition of aggregation and disaggregation effects of 54.69% and 88.75%, respectively, while increasing the yield, enhancing water solubility, and decreasing cost. Conclusion: Biosynthesis of nanoparticles using green tea is a promising simple and economical drug-carrying approach to confer multiple pharmacophore molecules to Au NPs. This could be used to design new drug candidates to treat Alzheimer's disease. Keywords: gold nanoparticles, green synthesis, (-)-epigallocatechin-3-gallate, liquid chromatography tandem triple quadrupole mass spectrometry, amyloid β protein, green tea Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive progression. The Alzheimer's Disease International (ADI) 2018 Global Report stated that every three seconds, someone in the world will develop dementia. 1 Currently, the pathogenesis of AD is highly controversial, but the main pathological hallmark is the misfolding of extracellular amyloid β-protein (Aβ) and neurofibrillary tangles induced by intracellular tau proteins. 2,3 Consequently, inhibition of Aβ aggregation is considered to be one of the most effective strategies for the treatment of AD. A variety of chemicals, including peptides, 4 curcumin, 5 alginate, 6 resveratrol, 7 and quercetin, 8 have been shown to inhibit Aβ fibrillation. Therein, (-)-epigallocatechin-3-gallate (EGCG), one of the most effective substances for inhibiting Aβ aggregation and promoting mature fiber disaggregation, 9–12 was achieved through the interaction of its own phenolic ring with the aromatic residues of Aβ by hydrogen bonding, aromatic stacking, and hydrophobicity. 13,14 Furthermore, in addition to chelating metal ions and scavenging free radicals, 15–17 Seidler et al revealed that EGCG could disaggregate brain-derived tau fibrils in vitro, fully validating the wide array of therapeutic potential of EGCG. 18 However, the applicability of EGCG in humans has encountered with rather limited success largely due to its low stability, poor blood–brain barrier (BBB) permeability, and rapid metabolic clearance, 19 ultimately resulting in an absolute bioavailability of only 0.1%. 20 Accordingly, diversified forms of EGCG delivery systems have been designed in the clinical setup. 21–25 Istenič et al utilized liposomes to -Abstract Truncated-

Efficient inhibition of amyloid fibrillation and cytotoxicity of α-synuclein and human insulin using biosynthesized silver nanoparticles decorated by green tea polyphenols

Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis

Antioxidant Nanoparticles for Concerted Inhibition of α-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation

Exploring The Influence Of Carbon Nanoparticles On The Formation Of Beta-Sheet-Rich Oligomers Of Iapp(22-28) Peptide By Molecular Dynamics Simulation

Facile synthesis of EGCG modified Au nanoparticles and their inhibitory effects on amyloid protein aggregation

Enhancing anti-amyloidogenic properties and antioxidant effects of Scutellaria baicalensis polyphenols through novel nanoparticle formation

Green synthesis of silver nanoparticles using Phlebopus portentosus polysaccharide and their antioxidant, antidiabetic, anticancer, and antimicrobial activities

Biosynthesis and Characterization of Silver Nanoparticles Using Tribulus terrestris Seeds: Revealed Promising Antidiabetic Potentials

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity

Tryptophan-cardanol fluorescent nanoparticles inhibit α-synuclein aggregation and disrupt amyloid fibrils

A Peptide‐Polyphenol Coated Polypyrrole Nanoparticle for Synergetic Attenuation of Aggregation and Cytotoxicity of Amyloid‐β Fibrils

Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative

In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions

Screening Carbon Nano Materials for Preventing Amyloid Protein Aggregation by Adopting a Facile Method

Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study

Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives

Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of Α-Synuclein.

Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics

Natural Polyphenolic Nanodots for Alzheimer's Disease Treatment

Pleiotropic Functions and Biological Potentials of Silver Nanoparticles Synthesized by an Endophytic Fungus

Glucosamine conjugated gold nanoparticles modulate protein aggregation induced autophagic neuronal cell death via regulation of intracellular Parkin homeostasis